The Challenges and Promise of Neuroimaging in Psychiatry

[1]  T. Crow,et al.  CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA , 1976, The Lancet.

[2]  R Kono,et al.  Antibody titres to enterovirus type 70 in the 1981 Indian epidemic of acute haemorrhagic conjunctivitis. , 1981, Lancet.

[3]  Richard S. J. Frackowiak,et al.  A functional neuroanatomy of hallucinations in schizophrenia , 1995, Nature.

[4]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Krystal,et al.  Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. , 1998, The American journal of psychiatry.

[6]  Holly Moore,et al.  The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia , 1999, Biological Psychiatry.

[7]  W. Singer,et al.  Activation of Heschl’s Gyrus during Auditory Hallucinations , 1999, Neuron.

[8]  E. Kandel,et al.  Biology and the future of psychoanalysis: a new intellectual framework for psychiatry revisited. , 1999, The American journal of psychiatry.

[9]  David A Lewis,et al.  Catching Up on Schizophrenia Natural History and Neurobiology , 2000, Neuron.

[10]  S. Hyman,et al.  Molecular Neuropharmacology: A Foundation for Clinical Neuroscience , 2001 .

[11]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[12]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[13]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[14]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[15]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[16]  John H Krystal,et al.  Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. , 2003, Archives of general psychiatry.

[17]  E. Stern,et al.  The Emerging Dialogue Between Psychoanalysis and Neuroscience: Neuroimaging Perspectives , 2003, Journal of the American Psychoanalytic Association.

[18]  Michael Erb,et al.  Physiological self-regulation of regional brain activity using real-time functional magnetic resonance imaging (fMRI): methodology and exemplary data , 2003, NeuroImage.

[19]  L. Siever,et al.  Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide , 2004, Biological Psychiatry.

[20]  Mathias Schreckenberger,et al.  Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. , 2004, The American journal of psychiatry.

[21]  A. Grace,et al.  The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes , 2004, Neuropsychopharmacology.

[22]  D. Weinberger,et al.  Genes, dopamine and cortical signal-to-noise ratio in schizophrenia , 2004, Trends in Neurosciences.

[23]  John D E Gabrieli,et al.  Control over brain activation and pain learned by using real-time functional MRI. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Ioannidis.  Why Most Published Research Findings Are False , 2005, PLoS medicine.

[25]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[26]  Darin D Dougherty,et al.  Neuroimaging and the functional neuroanatomy of psychotherapy , 2005, Psychological Medicine.

[27]  B. Turetsky,et al.  Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. , 2005, Archives of general psychiatry.

[28]  A. Lozano,et al.  Deep Brain Stimulation for Treatment-Resistant Depression , 2005, Neuron.

[29]  J. Gross,et al.  The cognitive control of emotion , 2005, Trends in Cognitive Sciences.

[30]  J. Seamans,et al.  Dopaminergic modulation of short-term synaptic plasticity in fast-spiking interneurons of primate dorsolateral prefrontal cortex. , 2005, Journal of neurophysiology.

[31]  E. Bramon,et al.  Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. , 2006, The American journal of psychiatry.

[32]  Andreas Meyer-Lindenberg,et al.  Neural mechanisms in Williams syndrome: a unique window to genetic influences on cognition and behaviour , 2006, Nature Reviews Neuroscience.

[33]  D. Linden,et al.  How psychotherapy changes the brain – the contribution of functional neuroimaging , 2006, Molecular Psychiatry.

[34]  Karl J. Friston,et al.  Synaptic Plasticity and Dysconnection in Schizophrenia , 2006, Biological Psychiatry.

[35]  C. Siao,et al.  Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related Behavior , 2006, Science.

[36]  R. Upthegrove.  Interventions for Schizophrenia , 2006 .

[37]  Jeffrey H Meyer,et al.  Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. , 2007, Journal of psychiatry & neuroscience : JPN.

[38]  R. Kahn,et al.  Genetic influences on human brain structure: A review of brain imaging studies in twins , 2007, Human brain mapping.

[39]  P M Matthews,et al.  Guidelines for using proton MR spectroscopy in multicenter clinical MS studies , 2007, Neurology.

[40]  A. Isaksson,et al.  Cross-validation and bootstrapping are unreliable in small sample classification , 2008, Pattern Recognit. Lett..

[41]  R. DeRubeis,et al.  Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms , 2008, Nature Reviews Neuroscience.

[42]  J. Piven,et al.  Morphometric spatial patterns differentiating boys with fragile X syndrome, typically developing boys, and developmentally delayed boys aged 1 to 3 years. , 2008, Archives of general psychiatry.

[43]  D. Linden.  Brain imaging and psychotherapy: methodological considerations and practical implications , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[44]  Anna Rotarska-Jagiela,et al.  The corpus callosum in schizophrenia-volume and connectivity changes affect specific regions , 2008, NeuroImage.

[45]  C. Spencer,et al.  Identification of loci associated with schizophrenia by genome-wide association and follow-up , 2008, Nature Genetics.

[46]  Rainer Goebel,et al.  Combining multivariate voxel selection and support vector machines for mapping and classification of fMRI spatial patterns , 2008, NeuroImage.

[47]  M C Neale,et al.  A whole genome association study of neuroticism using DNA pooling , 2008, Molecular Psychiatry.

[48]  Nick C Fox,et al.  Automatic classification of MR scans in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[49]  R. DeCharms.  Applications of real-time fMRI , 2008, Nature Reviews Neuroscience.

[50]  M. Greicius.  Resting-state functional connectivity in neuropsychiatric disorders , 2008, Current opinion in neurology.

[51]  Mark Slifstein,et al.  Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride , 2008, Neuropsychopharmacology.

[52]  M. Brammer,et al.  Pattern Classification of Sad Facial Processing: Toward the Development of Neurobiological Markers in Depression , 2008, Biological Psychiatry.

[53]  M L Phillips,et al.  Neural systems underlying voluntary and automatic emotion regulation: toward a neural model of bipolar disorder , 2008, Molecular Psychiatry.

[54]  Marcus R. Munafò,et al.  Serotonin Transporter (5-HTTLPR) Genotype and Amygdala Activation: A Meta-Analysis , 2008, Biological Psychiatry.

[55]  M. Phillips,et al.  A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder , 2008, Molecular Psychiatry.

[56]  M. Yücel,et al.  Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. , 2007, Schizophrenia bulletin.

[57]  W. Drevets,et al.  Imaging phenotypes of major depressive disorder: genetic correlates , 2009, Neuroscience.

[58]  Andrew J. Saykin,et al.  Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.

[59]  H. Möller,et al.  Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. , 2009, Archives of general psychiatry.

[60]  C. Antke,et al.  In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders , 2009, Behavioural Brain Research.

[61]  Derek K. Jones,et al.  Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans , 2009, Proceedings of the National Academy of Sciences.

[62]  R Cameron Craddock,et al.  Disease state prediction from resting state functional connectivity , 2009, Magnetic resonance in medicine.

[63]  S. Potkin,et al.  Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia , 2009, Molecular Psychiatry.

[64]  R. Feil,et al.  cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour. , 2009, Handbook of experimental pharmacology.

[65]  Marie Chupin,et al.  Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging , 2009, NeuroImage.

[66]  C. DeCarli,et al.  Bivariate Heritability of Total and Regional Brain Volumes: The Framingham Study , 2009, Alzheimer disease and associated disorders.

[67]  Dean F Wong,et al.  The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development , 2009, Neuropsychopharmacology.

[68]  Daniel Mathalon,et al.  A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. , 2009, Schizophrenia bulletin.

[69]  S. Cichon,et al.  Neural Mechanisms of a Genome-Wide Supported Psychosis Variant , 2009, Science.

[70]  Derek K. Jones,et al.  Visual gamma oscillations and evoked responses: Variability, repeatability and structural MRI correlates , 2010, NeuroImage.

[71]  S. de Santi,et al.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. , 2010, Journal of Alzheimer's disease : JAD.

[72]  Jessica A. Turner,et al.  Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort , 2010, NeuroImage.

[73]  Michael Weiner,et al.  Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort , 2010, NeuroImage.

[74]  R. Wennberg,et al.  A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease , 2010, Annals of neurology.

[75]  A. Meyer-Lindenberg,et al.  Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis , 2010, Molecular Psychiatry.

[76]  J. Kehr,et al.  Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine. , 2010, Journal of psychiatric research.

[77]  Timothy P. L. Roberts,et al.  DTI Based Diagnostic Prediction of a Disease via Pattern Classification , 2010, MICCAI.

[78]  Daniel R. Weinberger,et al.  Imaging genetics—days of future past , 2010, NeuroImage.

[79]  Thomas E. Nichols,et al.  Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression , 2010, NeuroImage.

[80]  A. Beck,et al.  Cognitive theory and therapy of anxiety and depression: Convergence with neurobiological findings , 2010, Trends in Cognitive Sciences.

[81]  M. Keshavan,et al.  Corpus callosum deficits in antipsychotic-naïve schizophrenia: Evidence for neurodevelopmental pathogenesis , 2010, Psychiatry Research: Neuroimaging.

[82]  G. Aston-Jones,et al.  Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) , 2010, Neuropsychopharmacology.

[83]  P. Donnelly,et al.  Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype , 2008, Molecular Psychiatry.

[84]  P. Donnelly,et al.  Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype , 2008, Molecular Psychiatry.

[85]  Peter Kirsch,et al.  Brain function in carriers of a genome-wide supported bipolar disorder variant. , 2010, Archives of general psychiatry.

[86]  Ian Marshall,et al.  Functional Magnetic Resonance Imaging (fMRI) reproducibility and variance components across visits and scanning sites with a finger tapping task , 2010, NeuroImage.

[87]  A. Abi-Dargham,et al.  Neurochemical imaging in schizophrenia. , 2010, Current topics in behavioral neurosciences.

[88]  Rainer Goebel,et al.  Neurofeedback: A promising tool for the self-regulation of emotion networks , 2010, NeuroImage.

[89]  A. Takano.  The application of PET technique for the development and evaluation of novel antipsychotics. , 2010, Current pharmaceutical design.

[90]  H. Stefánsson,et al.  Supplementary webappendix , 2018 .

[91]  N. Craddock,et al.  Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. , 2010, Archives of general psychiatry.

[92]  The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development. , 2010, Current opinion in investigational drugs.

[93]  Jeffrey L. Cummings,et al.  Integrating ADNI results into Alzheimer's disease drug development programs 1 1 Prepared for a special issue of Neurobiology of Aging on the Alzheimer's Disease Neuroimaging Initiative (ADNI). , 2010, Neurobiology of Aging.

[94]  W. Jagust,et al.  The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core , 2010, Alzheimer's & Dementia.

[95]  D. Segal.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) , 2010 .

[96]  Thomas E. Nichols,et al.  Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach , 2010, NeuroImage.

[97]  Carl-Fredrik Westin,et al.  Biomarkers for Identifying First-Episode Schizophrenia Patients Using Diffusion Weighted Imaging , 2010, MICCAI.

[98]  Wendy R. Sanhai,et al.  Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives , 2010, Nature Reviews Drug Discovery.

[99]  Gaohong Wu,et al.  Reliability and precision of pseudo‐continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O‐water PET in elderly subjects at risk for Alzheimer's disease , 2010, NMR in biomedicine.

[100]  David M. Lovinger,et al.  Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum , 2010, Neuropharmacology.

[101]  P. Holmans.  Statistical methods for pathway analysis of genome-wide data for association with complex genetic traits. , 2010, Advances in genetics.

[102]  M. First.  Paradigm Shifts and the Development of the Diagnostic and Statistical Manual of Mental Disorders: Past Experiences and Future Aspirations , 2010, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[103]  Andreas Meyer-Lindenberg,et al.  From maps to mechanisms through neuroimaging of schizophrenia , 2010, Nature.

[104]  Steven C. R. Williams,et al.  Describing the Brain in Autism in Five Dimensions—Magnetic Resonance Imaging-Assisted Diagnosis of Autism Spectrum Disorder Using a Multiparameter Classification Approach , 2010, The Journal of Neuroscience.

[105]  Tony J. Simon,et al.  22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia , 2010, Nature Reviews Neuroscience.

[106]  Richard J. Davidson,et al.  Amygdalar and hippocampal substrates of anxious temperament differ in their heritability , 2010, Nature.

[107]  E. Nestler,et al.  Linking molecules to mood: new insight into the biology of depression. , 2010, The American journal of psychiatry.

[108]  M. Frank,et al.  Neurogenetics and Pharmacology of Learning, Motivation, and Cognition , 2011, Neuropsychopharmacology.

[109]  P. Thompson,et al.  Multilocus Genetic Analysis of Brain Images , 2011, Front. Gene..

[110]  Karmen K. Yoder,et al.  Test–retest variability of [11C]raclopride‐binding potential in nontreatment‐seeking alcoholics , 2011, Synapse.

[111]  Nick C. Fox,et al.  Biomarkers for Alzheimer's disease therapeutic trials , 2011, Progress in Neurobiology.

[112]  John P A Ioannidis,et al.  Excess significance bias in the literature on brain volume abnormalities. , 2011, Archives of general psychiatry.

[113]  J O Rinne,et al.  Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[114]  P. Thompson,et al.  Heritability of Working Memory Brain Activation , 2011, The Journal of Neuroscience.

[115]  Matti Laine,et al.  Reproducibility of Striatal and Thalamic Dopamine D2 Receptor Binding Using [11C]raclopride with High-Resolution Positron Emission Tomography , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[116]  A. Lawrence,et al.  Dorsolateral Prefrontal-Aminobutyric Acid in Men Predicts Individual Differences in Rash Impulsivity , 2011 .

[117]  Renaud Jardri,et al.  Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis. , 2011, The American journal of psychiatry.

[118]  Michael Weiner,et al.  Voxelwise gene-wide association study (vGeneWAS): Multivariate gene-based association testing in 731 elderly subjects , 2011, NeuroImage.

[119]  Daniel H. Mathalon,et al.  A Roadmap for the Development and Validation of Event-Related Potential Biomarkers in Schizophrenia Research , 2011, Biological Psychiatry.

[120]  D. Weinberger,et al.  Reproducibility of prefrontal γ‐aminobutyric acid measurements with J‐edited spectroscopy , 2011, NMR in biomedicine.

[121]  D. Linden,et al.  Neurophysiology of Cognitive Dysfunction in Schizophrenia , 2011 .

[122]  A W Toga,et al.  Genome-wide association reveals dopamine-related genetic effects on caudate volume , 2011, Molecular Psychiatry.

[123]  R. Murray,et al.  Striatal dopamine synthesis capacity in twins discordant for schizophrenia , 2011, Psychological Medicine.

[124]  G. Northoff,et al.  Discovering imaging endophenotypes for major depression , 2011, Molecular Psychiatry.

[125]  Daniel H. Mathalon,et al.  Using Brain Imaging Measures in Studies of Procognitive Pharmacologic Agents in Schizophrenia: Psychometric and Quality Assurance Considerations , 2011, Biological Psychiatry.

[126]  R. Goebel,et al.  Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Treatment of Parkinson's Disease , 2011, The Journal of Neuroscience.

[127]  D. Geschwind,et al.  Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task. , 2011, Cerebral cortex.

[128]  L. Farde,et al.  Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia , 2011, CNS neuroscience & therapeutics.

[129]  V. van de Ven,et al.  The brain's voices: comparing nonclinical auditory hallucinations and imagery. , 2011, Cerebral cortex.

[130]  P. McGorry,et al.  Age of onset and timing of treatment for mental and substance use disorders: implications for preventive intervention strategies and models of care , 2011, Current opinion in psychiatry.

[131]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[132]  A. Bechdolf,et al.  Prediction and prevention of schizophrenia: what has been achieved and where to go next? , 2011, World psychiatry : official journal of the World Psychiatric Association.

[133]  B. Puri,et al.  The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia , 2011, Expert review of neurotherapeutics.

[134]  Andreas Heinz,et al.  Test–retest reliability of resting-state connectivity network characteristics using fMRI and graph theoretical measures , 2012, NeuroImage.

[135]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[136]  John J. Foxe,et al.  A NOS1 variant implicated in cognitive performance influences evoked neural responses during a high density EEG study of early visual perception , 2012, Human brain mapping.

[137]  D. E. Linden,et al.  Biological pathways to adaptability – interactions between genome, epigenome, nervous system and environment for adaptive behavior , 2012, Genes, brain, and behavior.

[138]  S. Muthukumaraswamy,et al.  Functional and structural correlates of the aging brain: Relating visual cortex (V1) gamma band responses to age‐related structural change , 2012, Human brain mapping.

[139]  S. Francis,et al.  Correspondence of human visual areas identified using functional and anatomical MRI in vivo at 7 T , 2012, Journal of magnetic resonance imaging : JMRI.

[140]  Leif D. Nelson,et al.  Data from Paper “False-Positive Psychology: Undisclosed Flexibility in Data Collection and Analysis Allows Presenting Anything as Significant” , 2014 .